Shares of Cerebras Systems (CBRS) fell 3.6% to $177.50 in Tuesday's trading session, even as the artificial intelligence chip maker announced a significant data center partnership in Finland. The stock has dropped more than 42% over the trailing twelve months and currently trades over 15% below its 20-day moving average.

Finland Data Center Partnership

The Finnish collaboration involves Compute Nordic Finland and covers a new AI data center located in Mikkeli. The installation, planned for phased development, will ultimately deliver 165 MW of contracted IT capacity, with the initial 50 MW phase already under development.

Under the agreement's structure, each service order carries a seven-year commitment, providing Cerebras with stable, long-term infrastructure to power its AI computing platform. The initiative is expected to create employment opportunities throughout the Mikkeli area.

The Nordic region has become a hub for AI data center construction, with Finland attracting large-scale compute investments in part because of its abundant renewable energy, cool climate that reduces cooling costs, and existing power and fiber infrastructure. For Cerebras, securing dedicated capacity is a strategic necessity in a market where AI compute supply has been constrained by data center availability, and the 165 MW commitment adds to the more than 600 MW of capacity the company has already secured operationally or contractually.

A share price decline alongside favorable news is not unusual. Market conditions were broadly challenging, with the Nasdaq (QQQ) sliding 1.5% and the S&P 500 retreating 0.76%. AI infrastructure stocks typically track broader growth sentiment.

From a technical perspective, CBRS sits below both its 20-day SMA of $212.57 and its 50-day SMA of $203.90. The MACD indicator is beneath its signal line with a negative histogram, indicating weakening momentum. Critical support stands at $173.50, just above the 52-week low of $160.81.

Ark Invest Increases Position

Despite the stock's decline, Ark Invest has been actively accumulating shares. On Aug. 25, Ark acquired 93,290 CBRS shares across several ETFs, totaling approximately $17.2 million, following earlier purchases completed in August.

Cathie Wood's investment thesis centers on Cerebras' competitive advantage in AI inference. The company's CS-4 system reportedly delivers up to 30 times faster inference performance compared to GPU-based solutions. Cerebras is also collaborating with AMD on a disaggregated inference architecture that provides up to five times greater throughput per watt in specific configurations.

The emphasis on inference reflects a broader industry shift: as AI deployments move from training models to running them at scale, inference workloads are expected to drive a growing share of AI compute demand, and Cerebras is positioning its wafer-scale technology and cloud offering against GPU incumbents led by Nvidia, which dominates the AI accelerator market.

The company maintains strategic partnerships with OpenAI, AWS, and AMD, while building an inference cloud business to complement its hardware revenue streams.

Strong Growth, Premium Pricing

Cerebras reported Q2 revenue of $180.1 million, up 74% year over year. Core revenue climbed 103% YOY to $209.9 million, while cloud and services revenue surged 287% YOY to $127.7 million and core gross margin advanced to 41%.

Management raised full-year fiscal 2026 core revenue guidance to a range of $880 million to $890 million, and set third-quarter core revenue guidance at $214 million to $216 million.

The company ended Q2 with $8.6 billion in cash, restricted cash, and short-term investments, alongside $25.4 billion in remaining performance obligations. It has also secured more than 600 MW of data center capacity either operational or contractually committed.

The valuation carries a significant premium: with a market capitalization of roughly $42.5 billion against annual sales of approximately $510 million, the price-to-sales multiple stands at 60 times. The company continues to report GAAP losses. That multiple reflects investor expectations that Cerebras can convert its remaining performance obligations and data center commitments into sustained high growth, and it leaves the stock sensitive to any shortfall in execution—a dynamic underscored by the 42% trailing decline even as fundamentals expand.

Wall Street remains optimistic despite the elevated valuation. Among 11 analysts covering the stock, eight assign "Strong Buy" ratings, one "Moderate Buy," and two "Hold." The consensus price target is $283.91. UBS maintains a $330 objective, Morgan Stanley lifted its target to $279, and Wedbush raised its forecast to $290.

The next earnings announcement is projected for November 19, 2026, with analyst consensus anticipating revenue of $214.90 million and an EPS loss of 14 cents. That report will be the next checkpoint for whether the raised fiscal 2026 guidance and the ramp of contracted capacity, including the Mikkeli facility, stay on track.